Annovis Bio Stock Price To Sales

ANVS Stock  USD 6.65  0.14  2.06%   
Annovis Bio fundamentals help investors to digest information that contributes to Annovis Bio's financial success or failures. It also enables traders to predict the movement of Annovis Stock. The fundamental analysis module provides a way to measure Annovis Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Annovis Bio stock.
Last ReportedProjected for Next Year
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Annovis Bio Company Price To Sales Analysis

Annovis Bio's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Annovis Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Annovis Bio is extremely important. It helps to project a fair market value of Annovis Stock properly, considering its historical fundamentals such as Price To Sales. Since Annovis Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Annovis Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Annovis Bio's interrelated accounts and indicators.
0.920.75-0.360.520.21-0.040.990.12-0.150.23-0.15-0.920.70.890.920.67-0.1-0.1-0.1
0.920.5-0.030.410.21-0.420.910.240.00.210.02-0.90.430.930.90.490.230.230.23
0.750.5-0.880.34-0.050.450.76-0.24-0.12-0.03-0.21-0.660.980.540.670.9-0.66-0.66-0.66
-0.36-0.03-0.88-0.180.15-0.75-0.370.430.20.150.320.27-0.89-0.12-0.28-0.780.870.870.87
0.520.410.34-0.180.820.190.410.69-0.130.85-0.16-0.170.210.160.170.17-0.06-0.06-0.06
0.210.21-0.050.150.82-0.030.090.81-0.20.98-0.220.12-0.19-0.11-0.12-0.190.120.120.12
-0.04-0.420.45-0.750.19-0.03-0.04-0.32-0.370.01-0.450.170.5-0.32-0.160.32-0.78-0.78-0.78
0.990.910.76-0.370.410.09-0.040.0-0.170.1-0.17-0.960.730.930.960.71-0.09-0.09-0.09
0.120.24-0.240.430.690.81-0.320.00.350.870.360.16-0.39-0.1-0.16-0.380.340.340.34
-0.150.0-0.120.2-0.13-0.2-0.37-0.170.35-0.110.980.14-0.18-0.12-0.14-0.20.110.110.11
0.230.21-0.030.150.850.980.010.10.87-0.11-0.130.12-0.17-0.1-0.12-0.180.110.110.11
-0.150.02-0.210.32-0.16-0.22-0.45-0.170.360.98-0.130.12-0.26-0.09-0.12-0.290.180.180.18
-0.92-0.9-0.660.27-0.170.120.17-0.960.160.140.120.12-0.67-0.98-1.0-0.68-0.01-0.01-0.01
0.70.430.98-0.890.21-0.190.50.73-0.39-0.18-0.17-0.26-0.670.540.680.92-0.68-0.68-0.68
0.890.930.54-0.120.16-0.11-0.320.93-0.1-0.12-0.1-0.09-0.980.540.980.60.170.170.17
0.920.90.67-0.280.17-0.12-0.160.96-0.16-0.14-0.12-0.12-1.00.680.980.690.010.010.01
0.670.490.9-0.780.17-0.190.320.71-0.38-0.2-0.18-0.29-0.680.920.60.69-0.48-0.48-0.48
-0.10.23-0.660.87-0.060.12-0.78-0.090.340.110.110.18-0.01-0.680.170.01-0.481.01.0
-0.10.23-0.660.87-0.060.12-0.78-0.090.340.110.110.18-0.01-0.680.170.01-0.481.01.0
-0.10.23-0.660.87-0.060.12-0.78-0.090.340.110.110.18-0.01-0.680.170.01-0.481.01.0
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, Annovis Bio has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.

Annovis Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Annovis Bio's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Annovis Bio could also be used in its relative valuation, which is a method of valuing Annovis Bio by comparing valuation metrics of similar companies.
Annovis Bio is currently under evaluation in price to sales category among its peers.

Annovis Bio Current Valuation Drivers

We derive many important indicators used in calculating different scores of Annovis Bio from analyzing Annovis Bio's financial statements. These drivers represent accounts that assess Annovis Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Annovis Bio's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap43.2M47.6M134.1M109.6M98.7M55.8M
Enterprise Value43.6M39.5M88.4M81.2M73.1M44.9M

Annovis Bio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Annovis Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Annovis Bio's managers, analysts, and investors.
Environmental
Governance
Social

Annovis Fundamentals

About Annovis Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Annovis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annovis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annovis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.